Question 1

IMVT vs MRK: which stock scores better overall?

Accepted Answer

Based on Q·Score, Merck & Company, Inc. (MRK) scores 6.7/10 versus Immunovant, Inc. (IMVT) at 5.1/10. The Q·Score measures five dimensions: Quality, Value, Growth, Safety, and Momentum. For informational purposes only — not financial advice.

Question 2

Which has better revenue growth: IMVT or MRK?

Accepted Answer

Merck & Company, Inc. (MRK) scores higher on Growth (6.2/10 vs 5.6/10). Immunovant, Inc. reports revenue growth while Merck & Company, Inc. reports (4.9% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.

Question 3

Is IMVT or MRK more attractively valued?

Accepted Answer

Merck & Company, Inc. (MRK) scores higher on Value (7.2/10 vs 5.7/10). Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.

Question 4

What do analysts say about IMVT vs MRK?

Accepted Answer

There are 17 analysts covering IMVT with a consensus price target of $40.29, and 27 analysts covering MRK with a consensus target of $129.74. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.

Question 5

Which is more profitable: IMVT or MRK?

Accepted Answer

Merck & Company, Inc. (MRK) scores higher on Quality (6.2/10 vs 1.6/10). Net profit margin: IMVT at 0.0%, MRK at 13.6%. Quality scores reflect profit margins, return on equity, and free cash flow generation.

Question 6

Which has stronger financial health: IMVT or MRK?

Accepted Answer

Merck & Company, Inc. (MRK) scores higher on Financial Health (7/10 vs 6.7/10). Market beta: IMVT at 0.67, MRK at 0.28. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.

Question 7

What are the market caps of IMVT and MRK?

Accepted Answer

Immunovant, Inc. (IMVT) has a market capitalisation of $5.5B, while Merck & Company, Inc. (MRK) has a market cap of $277.0B. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.

Question 8

Do IMVT or MRK pay dividends?

Accepted Answer

IMVT does not currently pay a dividend, while MRK pays a dividend yield of 3.03%. Dividend yields fluctuate with share price and company payout decisions.

Immunovant, Inc. vs Merck & Company, Inc. — Stock Comparison

Q·Score Breakdown

Analyst Consensus

Fundamentals